Risk of Sensorineural Hearing Loss in Patients with Vitiligo

被引：16

作者：

Fleissig, E. ^{[1
]}

Gross, M. ^{[2
]}

Ophir, I. ^{[1
]}

Elidan, J. ^{[2
]}

Bdolah-Abram, T. ^{[3
]}

Ingber, A. ^{[1
]}

机构：

[1] Hadassah Hebrew Univ Med Ctr, Dept Dermatol, IL-91120 Jerusalem, Israel

[2] Hadassah Hebrew Univ Med Ctr, Dept Otolaryngol Head & Neck Surg, IL-91120 Jerusalem, Israel

[3] Hadassah Hebrew Univ Med Ctr, Hadassah Med Sch, IL-91120 Jerusalem, Israel

来源：

AUDIOLOGY AND NEURO-OTOLOGY | 2013年 / 18卷 / 04期

关键词：

Vitiligo; Melanocyte; Sensorineural hearing loss; Vertigo; Inner ear; STRIA VASCULARIS; AUDIOLOGICAL ABNORMALITIES; INNER-EAR; MELANOCYTES;

D O I：

10.1159/000350337

中图分类号：

R36 [病理学]; R76 [耳鼻咽喉科学];

学科分类号：

100104 ; 100213 ;

摘要：

Objective: The purpose of this study was to determine the prevalence of hearing loss and vestibular symptoms among Israeli vitiligo patients as compared with healthy controls. Methods: 16 vitiligo patients and 16 healthy controls were enrolled in this prospective study. Vitiligo patients had undergone dermatologic evaluation and complete ENT evaluation. Results: Vitiligo patients demonstrated a significantly higher prevalence of sensorineural hearing loss (SNHL) (p = 0.001). A 'notch'-shaped audiogram was the most frequent type of audiogram found among vitiligo patients (p = 0.021). Patients with mucosal involvement as the primary site of onset had a significantly more normal hearing level (p = 0.004). Conclusions: Due to the high prevalence of SNHL amongst vitiligo patients, it is recommended that these patients undergo a complete hearing evaluation, avoiding ototoxic hazards if possible. (C) 2013 S. Karger AG, Basel

引用

页码：240 / 246

页数：7

共 26 条

[1] Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey [J].

Akay, B. N. ;

Bozkir, M. ;

Anadolu, Y. ;

Gullu, S. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (10) :1144-1150

[2] Degeneration of the stria vascularis during development in melanocyte-deficient mutant rats (Ws/Ws rats) [J].

Araki, S ;

Mizuta, K ;

Takeshita, T ;

Morita, H ;

Mineta, H ;

Hoshino, T .

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2002, 259 (06) :309-315

[3] High-frequency hearing and reflex latency in patients with pigment disorder [J].

Ardic, FN ;

Aktan, S ;

Kara, CO ;

Sanli, B .

AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1998, 19 (06) :365-369

[4] Audiological and transient evoked otoacoustic emission findings in patients with vitiligo [J].

Aslan, Sundus ;

Serarslan, Gamze ;

Teksoz, Emel ;

Dagli, Safak .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2010, 142 (03) :409-414

[5] Audiological abnormalities in patients with vitiligo [J].

Aydogan, K ;

Turan, OF ;

Onart, S ;

Karadogan, SK ;

Tunali, S .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2006, 31 (01) :110-113

[6] LIGHT (B(LT)), A MUTATION THAT CAUSES MELANOCYTE DEATH, AFFECTS STRIA VASCULARIS FUNCTION IN THE MOUSE INNER-EAR [J].

CABLE, J ;

JACKSON, IJ ;

STEEL, KP .

PIGMENT CELL RESEARCH, 1993, 6 (04) :215-225

[7] Pathophysiology of vitiligo [J].

Castanet, J ;

Ortonne, JP .

CLINICS IN DERMATOLOGY, 1997, 15 (06) :845-851

[8]

Clark J G, 1981, ASHA, V23, P493

[9] Otoacoustic emissions in the general adult population of Nord-Trondelag, Norway: II. Effects of noise, head injuries, and ear infections [J].

Engdahl, B ;

Tambs, K .

INTERNATIONAL JOURNAL OF AUDIOLOGY, 2002, 41 (01) :78-87

[10] NO EVIDENCE OF HEARING-LOSS IN PATIENTS WITH VITILIGO [J].

ESCALANTEUGALDE, C ;

POBLANO, A ;

DEOCA, EM ;

LAGUNES, R ;

SAUL, A .

ARCHIVES OF DERMATOLOGY, 1991, 127 (08) :1240-1240

← 1 2 3 →